Candela Medical has built its global reputation on laser and energy-based technology, supplying aesthetic medicine practitioners with devices used across dermatology, plastic surgery, and medical spa settings. Founded in 1970 and headquartered in Marlborough, Massachusetts, the company has decades of documented clinical application behind its core platforms, giving it a distinctive position among device manufacturers serving the aesthetics market.
The company's portfolio spans laser, light, and radiofrequency systems designed for a broad range of skin and body treatments, including vascular lesions, pigmentation, hair removal, skin resurfacing, and body contouring. Key platform families, including the PicoWay picosecond laser and the GentleMax Pro, are widely referenced across professional training programmes and clinical literature. This depth of product range allows practitioners to address multiple indications from a single supplier relationship.
Candela distributes through a combination of direct sales teams and international distribution partners, giving it a presence across North America, Europe, Asia-Pacific, and beyond. The company serves aesthetic clinics, dermatology practices, hospitals, and medical spas, supporting customers with clinical education and training resources that are regarded as a practical differentiator in the capital-equipment segment.
Operating within the medical aesthetics device sector, Candela sits alongside a small group of established names whose longevity in laser technology has produced a catalogue validated over multiple product generations. The company was taken private and later returned to growth-focused ownership, reflecting ongoing investor confidence in the medical aesthetics market.
Further information is available at candelamedical.com.